TAMPA, Fla. – Nearly 80 million Americans – one out of every four people – are infected with human papillomavirus (HPV). And of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the United States.
Moffitt Cancer Center has partnered with 69 other National Cancer Institute (NCI)-designated cancer centers, as well as the American Cancer Society, American Association for Cancer Research, American Society for Clinical Oncology, Association of American Cancer Institutes and America Society of Preventive Oncology, to issue a statement urging for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer. These institutions collectively recognize insufficient vaccination as a public health threat and call upon the nations’ physicians, parents and young adults to take advantage of this rare opportunity to eliminate several different types of cancer in men and women.
“We have the opportunity to eliminate multiple HPV-related cancers beginning with cervical cancer. To accomplish this goal, we need to utilize our most important tool – HPV vaccination,” said Anna R. Giuliano, Ph.D., director of the
Article originally posted at